These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 28779229)

  • 101. Measurement of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMP) in blood and urine: potential clinical applications.
    Zucker S; Doshi K; Cao J
    Adv Clin Chem; 2004; 38():37-85. PubMed ID: 15521188
    [No Abstract]   [Full Text] [Related]  

  • 102. TIMP-1: is surrogate testing for extracellular matrix remodelling ready for clinical translation or only an Icelandic phenomenon?
    Giannitsis E; Katus HA
    Eur Heart J; 2017 Dec; 38(46):3431-3433. PubMed ID: 29194482
    [No Abstract]   [Full Text] [Related]  

  • 103. Cytokines and matrix metalloproteinases as potential biomarkers in chronic heart failure.
    Deardorff R; Spinale FG
    Biomark Med; 2009 Oct; 3(5):513-523. PubMed ID: 20161487
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Contribution of circulating biomarkers to unravel the role of extracellular matrix in hypertensive cardiac remodelling.
    Beaumont J; González A; López B; Ravassa S; Díez J
    J Hypertens; 2012 Jan; 30(1):34-7. PubMed ID: 22157583
    [No Abstract]   [Full Text] [Related]  

  • 105. An Improved Diagnostic of the
    Lavrova AI; Postnikov EB
    Diagnostics (Basel); 2022 Nov; 12(11):. PubMed ID: 36428907
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Biomarkers in heart failure: the importance of inconvenient details.
    Miller WL; Jaffe AS
    ESC Heart Fail; 2016 Mar; 3(1):3-10. PubMed ID: 27774262
    [TBL] [Abstract][Full Text] [Related]  

  • 107. [Extracellular matrix biomarkers for cardiac diseases].
    Okada M
    Nihon Yakurigaku Zasshi; 2018; 152(4):208. PubMed ID: 30298843
    [No Abstract]   [Full Text] [Related]  

  • 108. Biological variation and reference change value as decision criteria in clinical use of tumor biomarkers. Are they really useful?
    Dittadi R; Fabricio ASC; Gion M
    Clin Chem Lab Med; 2022 May; 60(6):e136-e137. PubMed ID: 35263822
    [No Abstract]   [Full Text] [Related]  

  • 109. Matrix Metalloproteinase 2 as a Pharmacological Target in Heart Failure.
    Gonçalves PR; Nascimento LD; Gerlach RF; Rodrigues KE; Prado AF
    Pharmaceuticals (Basel); 2022 Jul; 15(8):. PubMed ID: 35893744
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Moxibustion Improves Chronic Heart Failure by Inhibiting Autophagy and Inflammation via Upregulation of mTOR Expression.
    Li Q; Wang W; Ma Q; Xia R; Gao B; Zhu G; Wang J
    Evid Based Complement Alternat Med; 2021; 2021():6635876. PubMed ID: 33603819
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Temporal Patterns of 14 Blood Biomarker candidates of Cardiac Remodeling in Relation to Prognosis of Patients With Chronic Heart Failure-The Bio- SH i FT Study.
    Bouwens E; Brankovic M; Mouthaan H; Baart S; Rizopoulos D; van Boven N; Caliskan K; Manintveld O; Germans T; van Ramshorst J; Umans V; Akkerhuis KM; Kardys I
    J Am Heart Assoc; 2019 Feb; 8(4):e009555. PubMed ID: 30760105
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Invasive hemodynamics and cardiac biomarkers to predict outcomes after percutaneous edge-to-edge mitral valve repair in patients with severe heart failure.
    Kreusser MM; Geis NA; Berlin N; Greiner S; Pleger ST; Bekeredjian R; Katus HA; Raake PW
    Clin Res Cardiol; 2019 Apr; 108(4):375-387. PubMed ID: 30191296
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Galectin-3 and ST2 as predictors of therapeutic success in high-risk patients undergoing percutaneous mitral valve repair (MitraClip).
    Dörr O; Walther C; Liebetrau C; Keller T; Sommer T; Boeder N; Bayer M; Bauer P; Möllmann H; Gaede L; Troidl C; Voss S; Bauer T; Hamm CW; Nef H
    Clin Cardiol; 2018 Sep; 41(9):1164-1169. PubMed ID: 29896861
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Specific biomarkers of myocardial inflammation and remodeling processes as predictors of mortality in high-risk patients undergoing percutaneous mitral valve repair (MitraClip).
    Dörr O; Walther C; Liebetrau C; Keller T; Tabert H; Boeder N; Bayer M; Bauer P; Möllmann H; Gaede L; Troidl C; Voss S; Bauer T; Hamm CW; Nef H
    Clin Cardiol; 2018 Apr; 41(4):481-487. PubMed ID: 29663512
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Association of Plasma Matrix Metalloproteinase and Tissue Inhibitors of Matrix Metalloproteinase Levels With Adverse Treatment Outcomes Among Patients With Pulmonary Tuberculosis.
    Kumar NP; Moideen K; Nancy A; Viswanathan V; Thiruvengadam K; Sivakumar S; Hissar S; Nair D; Banurekha VV; Kornfeld H; Babu S
    JAMA Netw Open; 2020 Dec; 3(12):e2027754. PubMed ID: 33258908
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Plasma matrix metalloproteinase and inhibitor profiles in patients with heart failure.
    Wilson EM; Gunasinghe HR; Coker ML; Sprunger P; Lee-Jackson D; Bozkurt B; Deswal A; Mann DL; Spinale FG
    J Card Fail; 2002 Dec; 8(6):390-8. PubMed ID: 12528092
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease.
    Ahmed SH; Clark LL; Pennington WR; Webb CS; Bonnema DD; Leonardi AH; McClure CD; Spinale FG; Zile MR
    Circulation; 2006 May; 113(17):2089-96. PubMed ID: 16636176
    [TBL] [Abstract][Full Text] [Related]  

  • 118. TIMPs and cardiac remodeling: 'Embracing the MMP-independent-side of the family'.
    Vanhoutte D; Heymans S
    J Mol Cell Cardiol; 2010 Mar; 48(3):445-53. PubMed ID: 19799912
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Biological variation of extracellular matrix biomarkers in patients with stable chronic heart failure.
    Täger T; Wiebalck C; Fröhlich H; Corletto A; Katus HA; Frankenstein L
    Clin Res Cardiol; 2017 Dec; 106(12):974-985. PubMed ID: 28779229
    [TBL] [Abstract][Full Text] [Related]  

  • 120.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.